These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1551119

  • 1. Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance.
    Zinkewich-Péotti K, Andrews PA.
    Cancer Res; 1992 Apr 01; 52(7):1902-6. PubMed ID: 1551119
    [Abstract] [Full Text] [Related]

  • 2. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
    Andrews PA, Albright KD.
    Cancer Res; 1992 Apr 01; 52(7):1895-901. PubMed ID: 1551118
    [Abstract] [Full Text] [Related]

  • 3. Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
    Naredi P, Heath DD, Enns RE, Howell SB.
    Cancer Res; 1994 Dec 15; 54(24):6464-8. PubMed ID: 7987844
    [Abstract] [Full Text] [Related]

  • 4. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells.
    Marverti G, Andrews PA.
    Clin Cancer Res; 1996 Jun 15; 2(6):991-9. PubMed ID: 9816260
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Energetic characteristics of cisplatin resistant ovarian carcinoma cells.
    Dorward AM, Singh G.
    Anticancer Res; 1996 Jun 15; 16(1):443-7. PubMed ID: 8615651
    [Abstract] [Full Text] [Related]

  • 8. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
    Hirama M, Isonishi S, Yasuda M, Ishikawa H.
    Oncol Rep; 2006 Nov 15; 16(5):997-1002. PubMed ID: 17016583
    [Abstract] [Full Text] [Related]

  • 9. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Andrews PA, Velury S, Mann SC, Howell SB.
    Cancer Res; 1988 Jan 01; 48(1):68-73. PubMed ID: 3335000
    [Abstract] [Full Text] [Related]

  • 10. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG.
    Cancer Res; 1994 Jul 01; 54(13):3500-5. PubMed ID: 8012973
    [Abstract] [Full Text] [Related]

  • 11. Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy.
    Moorehead RA, Armstrong SG, Wilson BC, Singh G.
    Cancer Res; 1994 May 15; 54(10):2556-9. PubMed ID: 7909492
    [Abstract] [Full Text] [Related]

  • 12. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
    Masuda H, Tanaka T, Matsuda H, Kusaba I.
    Cancer Res; 1990 Mar 15; 50(6):1863-6. PubMed ID: 2306738
    [Abstract] [Full Text] [Related]

  • 13. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 15; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 14. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.
    Richon VM, Schulte N, Eastman A.
    Cancer Res; 1987 Apr 15; 47(8):2056-61. PubMed ID: 3828995
    [Abstract] [Full Text] [Related]

  • 15. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA.
    Cancer Res; 1994 Mar 15; 54(6):1497-502. PubMed ID: 8137254
    [Abstract] [Full Text] [Related]

  • 16. Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.
    McLaughlin K, Stephens I, McMahon N, Brown R.
    Cancer Res; 1991 Apr 15; 51(8):2242-5. PubMed ID: 1901242
    [Abstract] [Full Text] [Related]

  • 17. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD, Zhang LX, Yue W, Zhu YF, Lu HJ, Liu X, Cen XT, Guan XY, Li CH.
    Ai Zheng; 2003 Apr 15; 22(4):337-45. PubMed ID: 12703984
    [Abstract] [Full Text] [Related]

  • 18. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 19. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM, Emondt JY, Floot BG, Dijkman R, Schrier PI, den Engelse L, Begg AC.
    Cancer Res; 1990 Jun 15; 50(12):3556-61. PubMed ID: 2340504
    [Abstract] [Full Text] [Related]

  • 20. Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine.
    Osmak M.
    Neoplasma; 1993 Jun 15; 40(2):97-101. PubMed ID: 8102478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.